Andrew Frye – SVP & President, APAC, Baxter
Andrew Frye of medtech giant Baxter outlines his management strategy for the diverse APAC region, how growth was…
Merlion Pharma
Last updated: 13.02.2014
Address: 41 Science Park Road, #04-03B The Gemini,Singapore Science Park II,Singapore 117610,Singapore
Tel: +(65) 6829-5600
Web: http://www.merlionpharma.com/
Company description
MerLion Pharmaceuticals Pte Ltd was formed in 2002 through the privatisation of the former Centre for Natural Product Research (CNPR), a unique unit of Singapore’s Institute of Molecular and Cell Biology (IMCB). MerLion Pharma acquired all of CNPR’s assets, including its unique collection of natural product samples. The company is now focused on developing its lead antibacterial candidate, finafloxacin.
Products and services
MerLion Pharma is progressing finafloxacin, a novel, highly differentiated antibacterial candidate. The compound, which has already shown potential for the treatment of urinary tract infections and the eradication of Helicobacter pylori, is being evaluated in critical care and hospital indications
Related
Singapore / Finding the Right Pharma Talent Post-COVID
Singapore – despite its modest USD 1.22 billion domestic market – has long been one of Asia’s leading…
Daniel Fung – CEO, Institute of Mental Health, Singapore
Singapore’s Institute of Mental Health offers a comprehensive range of psychiatric, rehabilitative, and…
APAC / Novartis APAC Oncology Head & Singapore Country President Kevin Zou
Kevin Zou highlights Novartis Oncology’s footprint and priorities in the diverse Asia-Pacific region, the…
Sanjay Prabhakaran – President, Asia Pacific, Hologic
Medtech industry veteran Sanjay Prabhakaran outlines the footprint and strategy of women’s health specialist…
Praful Chakkarwar – Country Manager, Novo Nordisk Pharma Singapore
Novo Nordisk Singapore’s Praful Chakkarwar explains how he leverages his experience in a range of geographies…
Nawal Roy – Founder & CEO, Holmusk
Nawal Roy of global digital health platform Holmusk which aims to establish data as a core utility to the treatment…
Carl Firth – CEO, ASLAN Pharmaceuticals
ASLAN Pharmaceuticals is a clinical-stage immunology-focused biopharmaceutical company. CEO Dr Carl Firth reveals…
Asia-Pacific / HSA: A Regulatory Gold Standard for the Region
As the most important pharma hub in its region, and one of the most important globally, many companies look to…
Choong May Ling, Mimi – CEO, Health Sciences Authority (HSA), Singapore
Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory…
Lance Little – Managing Director (Asia Pacific), Roche Diagnostics; Board…
Lance Little, managing director for Roche Diagnostics in Asia Pacific and board member of the Asia Pacific Medical…
Ashish D Pal – Managing Director, MSD Singapore, Malaysia & Brunei…
MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the…
